PWMG
WST icon

Private Wealth Management Group’s West Pharmaceutical WST Stock Holding History

Private Wealth Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.22K Hold
6
– – ﹤0.01% 1152
2026
Q2 		$2.15K Hold
6
– – ﹤0.01% 1143
2026
Q1 		$1.5K Hold
6
– – ﹤0.01% 1163
2025
Q4 		$1.65K Hold
6
– – ﹤0.01% 1148
2025
Q3 		$1.57K Hold
6
– – ﹤0.01% 1183
2025
Q2 		$1.31K Sell
6
-17
-74% -$3.63K ﹤0.01% 1197
2025
Q1 		$5.15K Buy
23
+21
+1,050% +$5.79K ﹤0.01% 717
2024
Q4 		$656 Hold
2
– – ﹤0.01% 1392
2024
Q3 		$601 Hold
2
– – ﹤0.01% 1398
2024
Q2 		$659 Hold
2
– – ﹤0.01% 1382
2024
Q1 		$792 Hold
2
– – ﹤0.01% 1342
2023
Q4 		$705 Buy
+2
New +$708 ﹤0.01% 1383

Other funds holding WST

ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Private Wealth Management Group's WST Position: Q3 2026 in Review

Private Wealth Management Group held its West Pharmaceutical (WST) position steady in Q3 2026 at 6 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

Private Wealth Management Group first reported a position in WST in Q4 2023 and has held it in 12 quarters since. The position peaked at $5.15K in Q1 2025. 273 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Private Wealth Management Group held 6 shares of West Pharmaceutical worth $2.22K as of Q3 2026.
  • Private Wealth Management Group left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #1152 holding.
  • Private Wealth Management Group first reported a position in West Pharmaceutical in Q4 2023 and has held it in 12 quarters since.
  • Private Wealth Management Group's West Pharmaceutical position peaked at $5.15K in Q1 2025.
  • 273 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.